Feb 7, 2025 • 7:30 AM EST Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
Oct 31, 2024 • 6:30 AM EDT Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction